These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 31357083)
1. Granzyme B production by activated B cells derived from breast cancer-draining lymph nodes. Arabpour M; Rasolmali R; Talei AR; Mehdipour F; Ghaderi A Mol Immunol; 2019 Oct; 114():172-178. PubMed ID: 31357083 [TBL] [Abstract][Full Text] [Related]
2. Increased B Regulatory Phenotype in Non-Metastatic Lymph Nodes of Node-Positive Breast Cancer Patients. Mehdipour F; Razmkhah M; Hosseini A; Bagheri M; Safaei A; Talei AR; Ghaderi A Scand J Immunol; 2016 Mar; 83(3):195-202. PubMed ID: 26708831 [TBL] [Abstract][Full Text] [Related]
3. The significance of cytokine-producing B cells in breast tumor-draining lymph nodes. Mehdipour F; Razmkhah M; Faghih Z; Bagheri M; Talei AR; Ghaderi A Cell Oncol (Dordr); 2019 Jun; 42(3):381-395. PubMed ID: 30850950 [TBL] [Abstract][Full Text] [Related]
4. Efficient Expansion of Human Granzyme B-Expressing B Cells with Potent Regulatory Properties. Chesneau M; Mai HL; Danger R; Le Bot S; Nguyen TV; Bernard J; Poullaouec C; Guerrif P; Conchon S; Giral M; Charreau B; Degauque N; Brouard S J Immunol; 2020 Nov; 205(9):2391-2401. PubMed ID: 32948686 [TBL] [Abstract][Full Text] [Related]
5. Correlation of 4-1BBL+ B Cells in Tumor Draining Lymph Nodes with Pathological Characteristics of Breast Cancer. Arabpour M; Ghods A; Shariat M; Talei AR; Mehdipour F; Ghaderi A Iran J Immunol; 2019 Jun; 16(2):108-116. PubMed ID: 31182685 [TBL] [Abstract][Full Text] [Related]
6. Human B cells differentiate into granzyme B-secreting cytotoxic B lymphocytes upon incomplete T-cell help. Hagn M; Sontheimer K; Dahlke K; Brueggemann S; Kaltenmeier C; Beyer T; Hofmann S; Lunov O; Barth TF; Fabricius D; Tron K; Nienhaus GU; Simmet T; Schrezenmeier H; Jahrsdörfer B Immunol Cell Biol; 2012 Apr; 90(4):457-67. PubMed ID: 21808264 [TBL] [Abstract][Full Text] [Related]
7. TNFR2 but not TNFR1 is the main TNFR expressed by B and T lymphocytes in breast cancer draining lymph nodes. Ghods A; Ghaderi A; Shariat M; Talei AR; Mehdipour F Immunol Lett; 2019 May; 209():36-44. PubMed ID: 30910714 [TBL] [Abstract][Full Text] [Related]
8. Visualization of cytolytic T cell differentiation and granule exocytosis with T cells from mice expressing active fluorescent granzyme B. Mouchacca P; Schmitt-Verhulst AM; Boyer C PLoS One; 2013; 8(6):e67239. PubMed ID: 23840635 [TBL] [Abstract][Full Text] [Related]
9. CD8-positive memory T cells in tumor-draining lymph nodes of patients with breast cancer. Vahidi Y; Bagheri M; Ghaderi A; Faghih Z BMC Cancer; 2020 Mar; 20(1):257. PubMed ID: 32228503 [TBL] [Abstract][Full Text] [Related]
10. Atypical Memory and Regulatory B Cell Subsets in Tumor Draining Lymph Nodes of Head and Neck Squamous Cell Carcinoma Correlate with Good Prognostic Factors. Norouzian M; Mehdipour F; Balouchi Anaraki S; Ashraf MJ; Khademi B; Ghaderi A Head Neck Pathol; 2020 Sep; 14(3):645-656. PubMed ID: 31691165 [TBL] [Abstract][Full Text] [Related]
11. The balance of regulatory and stimulatory B cell subsets in breast cancer draining lymph nodes correlates with tumor prognostic factors. Shariati S; Mehdipour F; Samadi M; Rasolmali R; Talei AR; Ghaderi A Life Sci; 2020 Sep; 257():118117. PubMed ID: 32693243 [TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of CD4+ and CD8+ T cells in tumor tissues, lymph nodes and the peripheral blood from patients with breast cancer. Riazi Rad F; Ajdary S; Omranipour R; Alimohammadian MH; Hassan ZM Iran Biomed J; 2015; 19(1):35-44. PubMed ID: 25605488 [TBL] [Abstract][Full Text] [Related]
13. CD5+ B cells from individuals with systemic lupus erythematosus express granzyme B. Hagn M; Ebel V; Sontheimer K; Schwesinger E; Lunov O; Beyer T; Fabricius D; Barth TF; Viardot A; Stilgenbauer S; Hepp J; Scharffetter-Kochanek K; Simmet T; Jahrsdörfer B Eur J Immunol; 2010 Jul; 40(7):2060-9. PubMed ID: 20394077 [TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological significance of cytotoxic lymphocytes in breast cancer and draining lymph nodes]. Wang HY; He JJ; Shi QF; Lai BC; Ding HY; Zheng J; Wang YL Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):384-8. PubMed ID: 19781344 [TBL] [Abstract][Full Text] [Related]
16. Determination of a CD4 Jafarinia M; Mehdipour F; Hosseini SV; Ghahramani L; Hosseinzadeh M; Ghaderi A Tumour Biol; 2016 Nov; 37(11):14659-14666. PubMed ID: 27619682 [TBL] [Abstract][Full Text] [Related]
17. Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes. Faghih Z; Erfani N; Haghshenas MR; Safaei A; Talei AR; Ghaderi A Immunol Lett; 2014; 158(1-2):57-65. PubMed ID: 24326038 [TBL] [Abstract][Full Text] [Related]
18. IL-17 and IL-4 producing CD8+ T cells in tumor draining lymph nodes of breast cancer patients: positive association with tumor progression. Faghih Z; Rezaeifard S; Safaei A; Ghaderi A; Erfani N Iran J Immunol; 2013 Dec; 10(4):193-204. PubMed ID: 24375061 [TBL] [Abstract][Full Text] [Related]
19. CD8 E J; Yan F; Kang Z; Zhu L; Xing J; Yu E Hum Immunol; 2018 Jun; 79(6):446-452. PubMed ID: 29544815 [TBL] [Abstract][Full Text] [Related]
20. IFNγ-IL-17-IL-22+CD4+ subset and IL-22-producing cells in tumor draining lymph nodes of patients with breast cancer. Salmanpour A; Rezaeifard S; Kiani R; Tahmasebi S; Faghih Z; Erfani N Breast Dis; 2022; 41(1):383-390. PubMed ID: 36189579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]